Sign in

CIK 0001367644 · Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
141902018
Phone
240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$145,792
in 2 filings, $146K under 10b5-1 plans

Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. DeGolyer Donald W −$126K Director sold 14% of stake
  2. Williams Paul Anthony −$20K SVP, Products Business sold 2% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-30 Fowler Neal Franklin Director Grant or award · Stock Option (Right to Buy) +11,296 11,296
2026-04-30 White Marvin L Director Grant or award +25,344 113,839
2026-04-30 White Marvin L Director Grant or award · Stock Option (Right to Buy) +11,296 11,296
2026-04-30 Harsanyi Zsolt Chairman Grant or award +25,344 149,076
2026-04-30 Harsanyi Zsolt Chairman Grant or award · Stock Option (Right to Buy) +11,296 11,296
2026-04-30 Richard Ronald Director Grant or award +25,344 123,761
2026-04-30 Richard Ronald Director Grant or award · Stock Option (Right to Buy) +11,296 11,296
2026-04-30 Katkin Keith Director Grant or award 10b5-1 +25,344 111,775
2026-04-30 Katkin Keith Director Sale 10b5-1 −15,481 $8.28 $128K 96,294
2026-04-30 Katkin Keith Director Grant or award · Stock Options (Right to Buy) 10b5-1 +11,296 11,296
2026-04-30 FOWLER JOHN D JR Director Grant or award +25,344 30,350
2026-04-30 FOWLER JOHN D JR Director Grant or award · Stock Option (Right to Buy) +11,296 11,296
2026-04-29 Lowry Simon C SVP, R&D, CMO Grant or award +100,111 177,914
2026-04-29 Perl Jessica SVP, General Counsel, Corp Sec Grant or award +104,282 165,286
2026-04-29 Hartzel William SVP, Bioservices Grant or award +100,111 187,299
2026-04-29 Williams Paul Anthony SVP, Products Business Grant or award +100,111 162,792
2026-04-29 Glessner Coleen EVP, Quality & Ethics, and CPL Grant or award +100,111 204,219
2026-04-29 PAPA JOSEPH C President and CEO Grant or award +187,708 493,153
2026-04-29 LINDAHL RICHARD S EVP, Chief Financial Officer Grant or award +162,680 378,047
2026-04-01 Williams Paul Anthony SVP, Products Business Sale 10b5-1 −4,000 $8.44 $34K 62,681

Page 2 of 17 · 330 trades